Global Cardiac Biomarkers Market: By Biomarker Type (Natriuretic Peptides (BNP And NT-ProBNP), Ischemia Modified Albumin, Creatine Kinase, Myoglobin, Troponins (T,I), and Others), By Disease Type (Acute Coronary Syndrome, Congestive Heart Failure, Atherosclerosis, Myocardial Infarction, and Others), By End User (Laboratory Testing, Point of Care Testing), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024Global cardiac biomarkers market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024
Market Dynamics: Cardiac Biomarkers Market
Increase in the prevalence of cardiovascular diseases anticipated to drive the growth of the cardiac biomarkers market. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) take the lives of 17.7 million people every year, 31% of all global deaths.
Free sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/cardiac-biomarkers-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Market Scope: Cardiac Biomarkers Market
Cardiac biomarkers market is segmented based on the biomarker type, disease type, and end user
Based on the biomarker type, the market is segmented into the following:
• Natriuretic Peptides (BNP And NT-ProBNP)
• Ischemia Modified Albumin
• Creatine Kinase
• Myoglobin
• Troponins (T,I)
• Others
Based on the disease type, the market is segmented into the following:
• Acute Coronary Syndrome
• Congestive Heart Failure
• Atherosclerosis
• Myocardial Infarction
• Others
Based on the end user, the market is segmented into the following:
• Laboratory Testing
• Point of Care Testing
Free TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/cardiac-biomarkers-market/#ulp-c654SbFYO64MsOhu[/URL]
Regional Analysis: Cardiac Biomarkers Market
Geographically, global cardiac biomarkers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America cardiac biomarkers market is the dominant market when compared with that of other regional markets owing to its deep-rooted healthcare infrastructure.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/cardiac-biomarkers-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Competition Assessment: Cardiac Biomarkers Market
Some of the players in the global cardiac biomarkers market include:
• Randox laboratories (UK)
• Thermo Fisher Scientific (U.S)
• Roche Diagnostics (Switzerland)
• Abbott Laboratories (U.S)
• Siemens Healthcare (Germany)
• Alere Inc. (U.S)
• Becton, Dickinson and Company (U.S)
• Bio-Rad Laboratories (U.S)
• BioMerieux (France)
• Beckman Coulter (U.S)
Notable Market Developments: Cardiac Biomarkers Market
? In January 2017, Roche has received 510(k) clearance for its Elecsys Troponin T Gen 5 STAT (TnT Gen 5 STAT) blood test for patients with a suspected heart attack.
Get access to full summary @
[URL]https://www.precisionbusinessinsights.com/market-reports/cardiac-biomarkers-market/[/URL]